BG
AZN icon

BlackRock Group’s AstraZeneca AZN Stock Holding History

BlackRock Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-62,023
Closed -$4.08M – 2977
2016
Q3 		$4.08M Buy
+62,023
New +$4.05M ﹤0.01% 1205
2016
Q1 		– Sell
-35,423
Closed -$2.4M – 3050
2015
Q4 		$2.4M Sell
35,423
-208,867
-85% -$13.7M ﹤0.01% 1386
2015
Q3 		$15.5M Sell
244,290
-107,538
-31% -$7.07M 0.01% 818
2015
Q2 		$22.4M Sell
351,828
-32,103
-8% -$2.2M 0.01% 784
2015
Q1 		$26.3M Sell
383,931
-12,569
-3% -$873K 0.01% 746
2014
Q4 		$27.9M Buy
396,500
+228,942
+137% +$16.4M 0.01% 722
2014
Q3 		$12M Buy
167,558
+6,561
+4% +$480K 0.01% 901
2014
Q2 		$12M Sell
160,997
-295,303
-65% -$21.3M 0.01% 904
2014
Q1 		$29.6M Buy
456,300
+16,000
+4% +$1.03M 0.02% 681
2013
Q4 		$26.1M Buy
440,300
+88,600
+25% +$4.81M 0.02% 695
2013
Q3 		$18.3M Buy
351,700
+97,900
+39% +$4.92M 0.01% 787
2013
Q2 		$12M Buy
+253,800
New +$12.9M 0.01% 816

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BlackRock Group's AZN Position: Q4 2016 in Review

BlackRock Group sold out of AstraZeneca (AZN) in Q4 2016, closing a stake of 62,023 shares — an estimated $4.08M sold.

BlackRock Group first reported a position in AZN in Q2 2013 and held it in 12 quarters. The position peaked at $29.6M in Q1 2014. 449 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

  • BlackRock Group reported no remaining AstraZeneca position as of Q4 2016 after selling out during the quarter.
  • BlackRock Group sold 62,023 AstraZeneca shares in Q4 2016, an estimated $4.08M.
  • BlackRock Group first reported a position in AstraZeneca in Q2 2013 and held it in 12 quarters.
  • BlackRock Group's AstraZeneca position peaked at $29.6M in Q1 2014.
  • 449 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.